Clinical trials
STEMI - ST Elevation Myocardial Infarction clinical trials
Below are recruiting stemi - st elevation myocardial infarction clinical trials, each written for real people, not researchers. We’re tracking 5 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05604131RecruitingPhase 2
Cardiac MRI-guided iron-chelator treatment after a heart attack
This Phase 2 trial tests whether giving deferiprone (an “iron-chelator,” meaning it helps remove excess iron) guided by cardiac MRI can improve outcomes after an acute anterior heart attack. It aims to study safety and benefit for people who can undergo MRI with contrast and meet specific heart, kidney, liver, and blood criteria.
Indianapolis, IndianaAges 18–79 - NCT06744322Recruiting
Fast discharge after a heart attack
This trial tests if it's safe to send patients home quickly after a mild heart attack. It may help those who had a successful procedure to open a blocked artery and are stable enough to leave the hospital sooner.
Wiener Neustadt, Lower AustriaAges 18 years+ - NCT07655479Recruiting
Switching to a stronger heart pump after heart attack
This trial tests whether switching to a more powerful heart pump (Impella 5.5) within 24 hours of a heart attack helps people whose hearts are still struggling despite a standard pump. It may be an option for patients who had a heart attack, received an Impella CP pump, but still need strong medication to keep blood flowing.
Düsseldorf, North Rhine-WestphaliaAges 18–77 - NCT03998319RecruitingPhase 3
Testing low-dose clot-busting drug after heart attack stent
This trial tests whether a low-dose clot-busting medicine placed into the heart artery after a primary stent can improve outcomes in people with a certain type of heart attack. It also involves short hospital follow-ups and a heart MRI to look at how the heart is recovering.
Bankstown, New South WalesAges 18 years+ - NCT06927739RecruitingPhase 2
Orticumab for heart artery inflammation after a heart attack
This trial tests a drug called orticumab to see if it can reduce inflammation in the arteries of the heart after a heart attack. It may help prevent future heart problems.
Los Angeles, CaliforniaAges 18 years+
Hear when a new STEMI - ST Elevation Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for stemi - st elevation myocardial infarction?
- Yes. Clin2 currently lists 5 recruiting stemi - st elevation myocardial infarction studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a stemi - st elevation myocardial infarction trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a stemi - st elevation myocardial infarction trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
- ST-segment Elevation Myocardial Infarction (STEMI)
- ST Elevation Myocardial Infarction
- Non-ST Elevation Myocardial Infarction
- Acute Myocardial Infarction With ST Elevation
- NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)
- Non-ST-Segment Elevation Myocardial Infarction (NSTEMI)
- ST Segment Elevation Myocardial Infarction
- Myocardial Infarction
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.